1-154158721-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001364681.2(TPM3):c.*248C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0437 in 495,356 control chromosomes in the GnomAD database, including 593 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.038 ( 154 hom., cov: 32)
Exomes 𝑓: 0.046 ( 439 hom. )
Consequence
TPM3
NM_001364681.2 3_prime_UTR
NM_001364681.2 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.788
Genes affected
TPM3 (HGNC:12012): (tropomyosin 3) This gene encodes a member of the tropomyosin family of actin-binding proteins. Tropomyosins are dimers of coiled-coil proteins that provide stability to actin filaments and regulate access of other actin-binding proteins. Mutations in this gene result in autosomal dominant nemaline myopathy and other muscle disorders. This locus is involved in translocations with other loci, including anaplastic lymphoma receptor tyrosine kinase (ALK) and neurotrophic tyrosine kinase receptor type 1 (NTRK1), which result in the formation of fusion proteins that act as oncogenes. There are numerous pseudogenes for this gene on different chromosomes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-154158721-G-A is Benign according to our data. Variant chr1-154158721-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1198687.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0513 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPM3 | NM_001364681.2 | c.*248C>T | 3_prime_UTR_variant | Exon 9 of 9 | NP_001351610.1 | |||
TPM3 | NM_001043352.2 | c.*248C>T | 3_prime_UTR_variant | Exon 8 of 8 | NP_001036817.1 | |||
TPM3 | NM_001043353.2 | c.*248C>T | 3_prime_UTR_variant | Exon 8 of 8 | NP_001036818.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPM3 | ENST00000368531 | c.*248C>T | 3_prime_UTR_variant | Exon 8 of 8 | 1 | ENSP00000357517.2 | ||||
TPM3 | ENST00000330188.13 | c.665-1000C>T | intron_variant | Intron 7 of 7 | 1 | ENSP00000339035.7 | ||||
TPM3 | ENST00000368533.8 | c.665-1000C>T | intron_variant | Intron 7 of 7 | 1 | ENSP00000357521.3 |
Frequencies
GnomAD3 genomes AF: 0.0382 AC: 5807AN: 152136Hom.: 155 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5807
AN:
152136
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0462 AC: 15861AN: 343102Hom.: 439 Cov.: 0 AF XY: 0.0473 AC XY: 8547AN XY: 180518 show subpopulations
GnomAD4 exome
AF:
AC:
15861
AN:
343102
Hom.:
Cov.:
0
AF XY:
AC XY:
8547
AN XY:
180518
Gnomad4 AFR exome
AF:
AC:
109
AN:
10474
Gnomad4 AMR exome
AF:
AC:
761
AN:
15002
Gnomad4 ASJ exome
AF:
AC:
219
AN:
11254
Gnomad4 EAS exome
AF:
AC:
730
AN:
23746
Gnomad4 SAS exome
AF:
AC:
2320
AN:
42966
Gnomad4 FIN exome
AF:
AC:
821
AN:
16278
Gnomad4 NFE exome
AF:
AC:
9936
AN:
201890
Gnomad4 Remaining exome
AF:
AC:
881
AN:
20022
Heterozygous variant carriers
0
749
1497
2246
2994
3743
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0381 AC: 5803AN: 152254Hom.: 154 Cov.: 32 AF XY: 0.0376 AC XY: 2800AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
5803
AN:
152254
Hom.:
Cov.:
32
AF XY:
AC XY:
2800
AN XY:
74436
Gnomad4 AFR
AF:
AC:
0.00936221
AN:
0.00936221
Gnomad4 AMR
AF:
AC:
0.0543279
AN:
0.0543279
Gnomad4 ASJ
AF:
AC:
0.0244816
AN:
0.0244816
Gnomad4 EAS
AF:
AC:
0.0273709
AN:
0.0273709
Gnomad4 SAS
AF:
AC:
0.0510162
AN:
0.0510162
Gnomad4 FIN
AF:
AC:
0.0535108
AN:
0.0535108
Gnomad4 NFE
AF:
AC:
0.0495192
AN:
0.0495192
Gnomad4 OTH
AF:
AC:
0.0540284
AN:
0.0540284
Heterozygous variant carriers
0
281
562
842
1123
1404
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
126
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 14, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at